FACTORS AFFECTING WARFARIN REQUIREMENTS - PROSPECTIVE POPULATION STUDY

被引:80
|
作者
ROUTLEDGE, PA
CHAPMAN, PH
DAVIES, DM
RAWLINS, MD
机构
[1] UNIV NEWCASTLE UPON TYNE, WOLFSON UNIT CLIN PHARMACOL, DEPT PHARMACOL SCI, NEWCASTLE UPON TYNE NE1 7RU, TYNE & WEAR, ENGLAND
[2] SHOTLEY BRIDGE GEN HOSP, DEPT CLIN PHARMACOL, DURHAM, ENGLAND
关键词
age; anticoagulation; sex; warfarin; weight;
D O I
10.1007/BF00558434
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In 228 ambulatory patients receiving treatment with warfarin, there was a progressive decline in the dose required to produce an equivalent degree of anticoagulant control with increasing age from the third decade onwards. However, the relationship between age and dose was significant only in patients receiving warfarin after episodes of venous thromboembolism or because of coronary artery disease. Patient weight was also related to warfarin requirements, although it was less important a determinant than age. © 1979 Springer-Verlag.
引用
收藏
页码:319 / 322
页数:4
相关论文
共 50 条
  • [41] Prospective study on warfarin and regional chemotherapy in patients with pancreatic carcinoma
    Nakchbandi, Wes
    Mueller, Herwart
    Singer, Manfred V.
    Loehr, J. Matthias
    Nakchbandi, Inaam A.
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2008, 17 (03) : 285 - 290
  • [42] Warfarin pharmacogenetics in a black Zimbabwean cohort: an observational prospective study
    Hidjo, Marie Madeleine M.
    Chikwambi, Zedias
    Ngwende, Gift
    Matenga, Jonathan A.
    Masimirembwa, Collen
    PHARMACOGENOMICS, 2023, 24 (10) : 529 - 538
  • [43] Efficacy and Safety of Warfarin for the Treatment of Venous Thromboembolism ― A Multicenter Prospective Observational Cohort Study in Japan (AKAFUJI Study)
    Nakamura, Mashio
    Tamaru, Satoshi
    Hirooka, Shigeki
    Hirayama, Atsushi
    Tsuji, Akihiro
    Hirata, Mitsuhiro
    Munemasa, Mitsuru
    Nakagawa, Izumi
    Toshima, Masahiro
    Shimokawa, Hiroaki
    Nishimura, Yuki
    Ogura, Toru
    Yamamoto, Takeshi
    Satokawa, Hirono
    Obayashi, Toru
    Yamada, Norikazu
    CIRCULATION JOURNAL, 2024, 88 (03) : 359 - 368
  • [44] Bleeding associated with self-medication in warfarin users: A prospective observational study in Ijui (Brazil)
    Colet, Christiane
    Amador, Tania Alves
    Castro, Stela
    Figueras, Albert
    Heineck, Isabela
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 58
  • [45] Assessment of Warfarin Dosing Requirements After Bariatric Surgery in Patients Requiring Long-Term Warfarin Therapy
    Irwin, Adriane N.
    McCool, Kathleen H.
    Delate, Thomas
    Witt, Daniel M.
    PHARMACOTHERAPY, 2013, 33 (11): : 1175 - 1183
  • [46] Study of target INR achievement, incidence of hemorrhagic complications and affecting factors after during warfarin treatment in western area of China
    Rui Shi
    Wei Wei
    Yanbiao Yang
    Shouyuan Yang
    Liping Yan
    Zongjie Zhu
    Scientific Reports, 15 (1)
  • [47] Small therapeutic window of warfarin in Japanese population
    Watanabe, Eiichi
    Journal of Cardiology, 2015, 65 (3-4) : 171 - 172
  • [48] Sensorimotor Factors Affecting Gait Variability in Older People-A Population-Based Study
    Callisaya, Michele L.
    Blizzard, Leigh
    McGinley, Jennifer L.
    Schmidt, Michael D.
    Srikanth, Velandai K.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2010, 65 (04): : 386 - 392
  • [49] Warfarin dosage adjustment strategy in Chinese population
    Yu, Zhe
    Ding, Ying-Long
    Lu, Fei
    Miao, Li-Yan
    Shen, Zhen-Ya
    Ye, Wen-Xue
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (06): : 9904 - 9910
  • [50] Genetic Associations With Stable Warfarin Dose Requirements in Han Chinese Patients
    Xu, Qingqing
    Zhang, Suli
    Wu, Chaoneng
    Xiong, Yuyu
    Niu, Jiamin
    Li, Fengzhen
    Zhu, Jinhang
    Shen, Lu
    Zhu, Bin
    Xing, Qinghe
    He, Lin
    Chen, Luan
    Li, Mo
    Li, Hua
    Ge, Junbo
    Qin, Shengying
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (01) : 105 - 111